Clinical presentation, hemorrhage risk, and outcome in patients with familial cavernous malformations: a pragmatic prospective analysis of 75 patients

Mohammed O. AlalfiDepartments of Neurologic Surgery and

Search for other papers by Mohammed O. Alalfi in
Current site
Google Scholar
PubMed
Close
,
Giuseppe LanzinoDepartments of Neurologic Surgery and

Search for other papers by Giuseppe Lanzino in
Current site
Google Scholar
PubMed
Close
 MD
, and
Kelly D. FlemmingNeurology, Mayo Clinic, Rochester, Minnesota

Search for other papers by Kelly D. Flemming in
Current site
Google Scholar
PubMed
Close
 MD
View More View Less
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $525.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $624.00
USD  $45.00
USD  $525.00
USD  $624.00
Print or Print + Online Sign in

OBJECTIVE

Newly diagnosed patients with a familial cavernous malformation (FCM) and their families are concerned about their future outlook, which is scarcely discussed in the literature. The authors studied a prospective contemporary cohort of patients with FCMs to assess demographics, mode of presentation, prospective risk of hemorrhage and seizures, need for surgery, and functional outcome over an extended interval.

METHODS

A prospectively maintained database beginning January 1, 2015, of patients diagnosed with a cavernous malformation (CM) was queried. Data on demographics, radiological imaging, and symptoms at first diagnosis were collected in adult patients who gave their consent to prospective contact. Follow-up was done using questionnaires, in-person visits, and medical record review to assess for prospective symptomatic hemorrhage (i.e., the first hemorrhage after enrollment in the database), seizure, functional outcome measured by the modified Rankin Scale (mRS), and treatment. The prospective hemorrhage rate was calculated by the number of prospective hemorrhages divided by patient-years of follow-up censored at last follow-up, first prospective hemorrhage, or death. A Kaplan-Meier curve of survival free of hemorrhage was obtained comparing patients with versus without hemorrhage at the time of presentation and compared with a log-rank test for p < 0.05.

RESULTS

A total of 75 patients with FCM were included, of whom 60% were female. The mean age at diagnosis was 41 ± 16 years. Most symptomatic or large lesions were located supratentorially. At first diagnosis, 27 patients had no symptoms, and the remaining were symptomatic. Over an average of 9.9 years, the rate of prospective hemorrhage was 4.0% per patient-year, and the rate of new seizure was 1.2% per patient-year, with 64% and 32% of patients experiencing at least one symptomatic hemorrhage and at least one seizure, respectively. Thirty-eight percent of the patients underwent at least 1 surgery and 5.3% underwent stereotactic radiosurgery. At the last follow-up, 83.0% of patients remained independent with an mRS score ≤ 2.

CONCLUSIONS

The authors’ findings provide clinically useful information on hemorrhage rate, seizure rate, the likelihood of surgery, and functional outcome. These findings can be helpful to practicing physicians when counseling patients with FCM and their families, who are often apprehensive about their future and well-being.

ABBREVIATIONS

CM = cavernous malformation; DVA = developmental venous anomaly; FCM = familial CM; FND = focal neurological deficit; mRS = modified Rankin Scale; SRS = stereotactic radiosurgery.
  • Collapse
  • Expand
  • 1

    Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D. Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol. 2009;5(12):659670.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Zafar A, Quadri SA, Farooqui M, et al. Familial cerebral cavernous malformations. Stroke. 2019;50(5):12941301.

  • 3

    Labauge P, Brunereau L, Lévy C, Laberge S, Houtteville JP. The natural history of familial cerebral cavernomas: a retrospective MRI study of 40 patients. Neuroradiology. 2000;42(5):327332.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Fox CK, Nelson J, McCulloch CE, et al. Seizure incidence rates in children and adults with familial cerebral cavernous malformations. Neurology. 2021;97(12):e1210e1216.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Al-Shahi Salman R, Berg MJ, Morrison L, Awad IA. Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Stroke. 2008;39(12):32223230.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Zabramski JM, Wascher TM, Spetzler RF, et al. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg. 1994;80(3):422432.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Taslimi S, Modabbernia A, Amin-Hanjani S, Barker FG II, Macdonald RL. Natural history of cavernous malformation: systematic review and meta-analysis of 25 studies. Neurology. 2016;86(21):19841991.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Horne MA, Flemming KD, Su IC, et al. Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data. Lancet Neurol. 2016;15(2):166173.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Morrison L, Akers A. Cerebral cavernous malformation, familial. In: Adam MP, Everman DB, Mirzaa GM et al. eds. GeneReviews® [Internet]. University of Washington, Seattle; February 24, 2003.

    • Search Google Scholar
    • Export Citation
  • 10

    Taslimi S, Ku JC, Modabbernia A, Macdonald RL. Hemorrhage, seizures, and dynamic changes of familial versus nonfamilial cavernous malformation: systematic review and meta-analysis. World Neurosurg. 2019;126:241246.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Shoubash L, Baldauf J, Matthes M, et al. Long-term outcome and quality of life after CNS cavernoma resection: eloquent vs. non-eloquent areas. Neurosurg Rev. 2022;45(1):649660.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Cornelius JF, Kürten K, Fischer I, Hänggi D, Steiger HJ. Quality of life after surgery for cerebral cavernoma: brainstem versus nonbrainstem location. World Neurosurg. 2016;95:315321.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    Lashkarivand A, Ringstad G, Eide PK. Surgery for brainstem cavernous malformations: association between preoperative grade and postoperative quality of life. Oper Neurosurg (Hagerstown). 2020;18(6):590598.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Dukatz T, Sarnthein J, Sitter H, et al. Quality of life after brainstem cavernoma surgery in 71 patients. Neurosurgery. 2011;69(3):689695.

  • 15

    Dammann P, Herten A, Santos AN, et al. Multimodal outcome assessment after surgery for brainstem cavernous malformations. J Neurosurg. 2021;135(2):401409.

    • Search Google Scholar
    • Export Citation
  • 16

    Rauschenbach L, Bartsch P, Santos AN, et al. Quality of life and mood assessment in conservatively treated cavernous malformation-related epilepsy. Brain Behav. 2022;12(6):e2595.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    Herten A, Chen B, Saban D, et al. Health-related quality of life in patients with untreated cavernous malformations of the central nervous system. Eur J Neurol. 2021;28(2):491499.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Bicalho VC, Bergmann A, Domingues F, Frossard JT, de Souza JPBM. Cerebral cavernous malformations: patient-reported outcome validates conservative management. Cerebrovasc Dis. 2017;44(5-6):313319.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Kumar S, Lanzino G, Flemming KD. Affected health domains in patients with brainstem cavernous malformations. Acta Neurochir (Wien). 2019;161(12):25212526.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20

    Akers A, Al-Shahi Salman R, Awad IA, et al. Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board clinical experts panel. Neurosurgery. 2017;80(5):665680.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21

    Shenkar R, Shi C, Rebeiz T, et al. Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations. Genet Med. 2015;17(3):188196.

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 233 233 233
Full Text Views 59 59 59
PDF Downloads 61 61 61
EPUB Downloads 0 0 0